Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment
Olympia Zarkotou(Tzaneion General Hospital), Athanasios Tsakris(National and Kapodistrian University of Athens), Vasileios Dragoumanos(Tzaneion General Hospital), Vassiliki Pitiriga(National and Kapodistrian University of Athens), Spyros Pournaras(National and Kapodistrian University of Athens), Paraskevi Tselioti(Tzaneion General Hospital), Kyriaki Ranellou(National and Kapodistrian University of Athens), Katerina Themeli-Digalaki(Tzaneion General Hospital), Athanasios Prekates(Tzaneion General Hospital)
Cited by 441
Related Papers
Data-based analysis, modelling and forecasting of the COVID-19 outbreak
|PLoS ONE|2020|965
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
|The Lancet Infectious Diseases|2017|521
Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages
|International Journal of Antimicrobial Agents|2012|502
Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues
|Clinical Microbiology and Infection|2010|349
Outbreak of Infections Caused by <i>Pseudomonas aeruginosa</i> Producing VIM-1 Carbapenemase in Greece
|Journal of Clinical Microbiology|2000|261